(Q36314862)

13 August 2017

1 reference

title

Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence (English)

1 reference

13 August 2017

1 reference

1 reference

Jerzy-Roch Nofer

1

1 reference

13 August 2017

Michael Walter

series ordinal

2

1 reference

13 August 2017

Gerd Assmann

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

1 November 2005

1 reference

Expert Review of Cardiovascular Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

1071-1086

1 reference

Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Atheroprotective effects of high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The role of the kidney in lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Regulation of reverse cholesterol transport and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The ABC transporter structure and mechanism: perspectives on recent research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Function of prokaryotic and eukaryotic ABC proteins in lipid transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Heterogeneity of lipoprotein particles in hepatic Golgi fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Biosynthesis of high density lipoprotein by chicken liver: conjugation of nascent lipids with apoprotein A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Potential role of ABCA7 in cellular lipid efflux to apoA-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

21 January 2018

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Role of Monocytes in Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Chemokines in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

HDL: a recipe for longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Unique lipoprotein phenotype and genotype associated with exceptional longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Historical claims and current interpretations of replicative aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Extension of life-span by introduction of telomerase into normal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Association between telomere length in blood and mortality in people aged 60 years or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Telomeres are double-strand DNA breaks hidden from DNA damage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

HDL as a target in the treatment of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

High-density lipoproteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Apolipoprotein A-I mimetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Molecular identification of high and low affinity receptors for nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Liver X Receptor Signaling Pathways in Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

LXRs: new therapeutic targets in atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.1071

10.1586/14779072.3.6.1071

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference